Soluble Fas-antigen in serum from cancer patients
Abbasova, S.G.; Kushlinskiĭ, N.E.; Murashev, A.N.; Kostanian, I.A.; Obusheva, M.N.; Nikogosian, S.O.; Britvin, T.A.; Bagirova, N.F.; Solov'ev, I.N.; Lipkin, V.M.; Trapeznikov, N.N.
Biulleten' Eksperimental'noi Biologii i Meditsiny 127(3): 328-331
1999
ISSN/ISBN: 0365-9615 PMID: 10225113 Document Number: 502755
Document emailed within 1 workday
Related Documents
Kinikli, G.ül.; Ateş, A.şk.; Turgay, M.; Aydoğan, N.; Tokgöz, G.ün. 2006: Serum-soluble Fas antigen level in patients with allergic rhinitis: its relation to specific immunotherapy Allergy and Asthma Proceedings 27(2): 145-147Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Kargi, A.; Yalcin, A.D.; Erin, N.; Savas, B.; H. Hüseyin Polat; Gorczynski, R.M. 2012: IL8 and Serum Soluble Trail Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients With Metastatic Colon Cancer Clinical Laboratory 58(5-6): 501-505
Lissoni, P.; Barni, S.; Tancini, G.; Viviani, S.; Rovelli, F.; Rescaldani, R.; Fiorelli, G. 1989: Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms Journal of Biological Regulators and Homeostatic Agents 3(3): 131-133
Melchiorri, L.; Martini, A.; Rizzo, R.; Berto, A.; Adinolfi, E.; Baricord, O.Roberto. 2002: Human leukocyte antigen-A, -B, -C and -DR alleles and soluble human leukocyte antigen class I serum level in Ménière's disease Acta Oto-Laryngologica. Supplementum 2002(548): 26-29
How, S.H.; Liam, C.K.; Jamalludin, A.R.; Chin, S.P.; Zal, A.B. 2006: Serum cancer antigen 125 in patients with pleural effusions Medical Journal of Malaysia 61(5): 558-563
Zmudziński, J.; Zmudzińska, M.; Niepsuj, K.; Lewandowski, J. 1988: Carcinoembryonic antigen levels in the serum and gastric juice of patients with cancer of the stomach and in patients with various non-neoplastic diseases of the digestive tract Polski Tygodnik Lekarski 43(47): 1496-1499
Kazama, T.; Katayama, T.; Yamazaki, N. 1985: Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer Hinyokika Kiyo. Acta Urologica Japonica 31(12): 2113-2119
Lang, B.A.; Kocent, A.; Nekulová, M.; Hlávková, J. 1984: Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer Neoplasma 31(1): 79-87
Shimano, T.; Monden, T.; Morimoto, H.; Mori, T. 1990: The relation between serum carcinoembryonic antigen (CEA) and response to chemotherapy in patients with advanced colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 2): 423-428
Stacker, S.A.; Thompson, C.H.; Sacks, N.P.; Tjandra, J.; Lowe, M.G.; Bishop, J.; McKenzie, I.F. 1988: Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2 Cancer Research 48(24 Part 1): 7060-7066
Hino, M.; Ogasawara, H.; Yoshii, A.; Yoneda, S.; Noguchi, Y.; Sakai, H.; Yoshida, K. 1992: Clinical significance of serum carcinoembryonic antigen in small cell lung cancer patients Nihon Kyobu Shikkan Gakkai Zasshi 30(2): 278-284
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Wilbanks, G.A.; Streilein, J.W. 1989: The differing patterns of antigen release and local retention following anterior chamber and intravenous inoculation of soluble antigen. Evidence that the eye acts as an antigen depot Regional Immunology 2(6): 390-398
Hirano, K.; Kawa, S.; Oguchi, H.; Kobayashi, T.; Yonekura, H.; Ogata, H.; Homma, T. 1987: Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels Journal of the National Cancer Institute 79(6): 1261-1268
Degtiarenko, V.I.; Zatsepin, N.I.; Rybakova, T.M.; Vasiutinskaia, L.A.; Dragomeetskiĭ, V.D. 1971: Complement fixing antibodies to the thermostable component of adenovirus type 12 T-antigen in the serum of cancer patients Voprosy Virusologii 16(4): 451-455
Menendez-Botet, C.J.; Oettgen, H.F.; Pinsky, C.M.; Schwartz, M.K. 1978: A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms Clinical Chemistry 24(6): 868-872
Manly, K.F.; Petrelli, N.; Anderson, G.R.; Emrich, L.J.; Herrera, L.; Mittelman, A. 1987: Expression of an unusual isozyme of lactate dehydrogenase in the serum of cancer patients and comparison with carcinoembryonic antigen Cancer Research 47(22): 6156-6160
Zhang, D.; Zhan, T.; Li, M.; Gu, J. 2017: Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy Zhonghua Wei Chang Wai Ke Za Zhi 20(5): 519-523
Williams, A.I.; Houba, V. 1972: Soluble serum antigens of P. falciparum in Nigerians. I. Local incidence of malarial soluble serum antigens and antibodies African Journal of Medical Sciences 3(4): 295-307